A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders
内感受暴露对低体重饮食失调青少年的有效性研究
基本信息
- 批准号:10571565
- 负责人:
- 金额:$ 78.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAdolescenceAdolescentAftercareAgeAnorexia NervosaAttitudeAwarenessBehavioralBlindedBody WeightChildChild RearingChronicClinicalCost of IllnessCuesDataData AnalysesDevelopmentDistalEatingEating BehaviorEating DisordersElectrophysiology (science)Eligibility DeterminationEtiologyEvaluationExposure toExtinctionFamilyFamily psychotherapyFoodFoundationsHealth Care CostsImpairmentInterventionLaboratoriesLearningMeasuresMediatingMediationMediatorMeta-AnalysisModelingOccupationsOutcomeParticipantPathologyPatientsPharmaceutical PreparationsProtocols documentationPublic HealthPublishingRandomized Controlled Clinical TrialsSelf EfficacyShapesSymptomsTestingTimeTreatment EfficacyWeightagedcomparative efficacyconditioningconfirmatory trialdepressive symptomsefficacy evaluationefficacy studyefficacy testingefficacy trialexperiencefeedingfollow-upfood avoidanceimprovedlearning extinctionlongitudinal datasetnovelprimary outcomesecondary outcomesevere psychiatric disordersexstandard caresuccesssystematic reviewtreatment adherencetreatment comparisontreatment effecttreatment response
项目摘要
Project Summary/Abstract
Low weight eating disorders, such as anorexia nervosa/atypical anorexia nervosa, are severe psychiatric
disorders that often develop in adolescence, have a chronic course, and evidence poor response to treatment
at great public health cost. Two core features of LW-EDs are food avoidance and preoccupation with shape
and weight. Preliminary data from our initial mechanism study indicate that family based interoceptive
exposure (FBT-E) therapy reduces food avoidance, increases autonomous eating and nonjudgement body
awareness, and enhances extinction learning to aversive food cues to a greater degree than existing family-
based therapy (FBT). Feasibility data indicated high retention, treatment fidelity, and established reliable
measures of treatment adherence despite similar short-term (6-week) within-treatment changes in expected
body weight. Long-term (6-month) follow-up of these interventions in open trial indicate significantly higher
expected body weight among those having received FBT-E. Short-term and long-term changes in weight were
highly correlated with changes in expected body weight. Consequently, we will test the confirmatory efficacy of
FBT-E vs FBT and 12-month follow-up in a parallel group randomized clinical controlled trial in 120
adolescents aged 12-18. We have three specific aims, including: (1) to determine short term and long term
efficacy of FBT-E vs FBT in expected body weight, global eating disorder symptoms, and clinical impairment;
(2) to determine efficacy of FBT-E vs. FBT on laboratory measures of autonomous eating, nonjudgmental body
awareness, and extinction learning; and (3) estimate whether temporal precedence and mechanistic value
(mediation) of early changes in autonomous eating, non-judgmental body awareness, and extinction learning
on treatment effects and longitudinal outcomes. Assessments and data analyses will be blinded to treatment.
With N=120 participants (n = 60 per group) we can detect moderate sized effects for primary and secondary
outcomes. Results will provide data to support novel treatment for LW-EDs and provide theoretical robust
model for understanding pathology for children and families that suffer with LW-EDs.
项目摘要/摘要
低体重进食障碍,如神经性厌食症/非典型神经性厌食症,是严重的精神疾病。
通常在青春期发展的疾病,具有慢性病程,并且有证据表明对治疗的反应很差
以巨大的公共卫生成本。LW-EDS的两个核心特征是避免食物和专注于形状
和体重。我们初步机制研究的初步数据表明,基于家庭的内感
暴露(FBT-E)疗法减少了对食物的回避,增加了自主进食和非判断性身体
意识,并在更大程度上增强对有害食物线索的灭绝学习--
基础疗法(FBT)。可行性数据表明,高保留率、治疗保真度和建立的可靠性
尽管预期的治疗内短期(6周)变化,但治疗依从性的衡量标准
体重。在开放试验中,这些干预措施的长期(6个月)随访显示显著更高
接受FBT-E治疗的人的预期体重。体重的短期和长期变化是
与预期体重的变化高度相关。因此,我们将测试
120例平行组随机临床对照试验中FBT-E与FBT的比较及12个月的随访
12-18岁的青少年。我们有三个具体目标,包括:(1)确定短期和长期
FBT-E与FBT在预期体重、全球进食障碍症状和临床损害方面的疗效比较;
(2)确定FBT-E与FBT对自主进食、非判断性身体实验室测量的有效性
意识和灭绝学习;以及(3)估计时间优先和机械价值
(调解)自主饮食、非判断性身体意识和消亡学习的早期变化
关于治疗效果和纵向结果。评估和数据分析将对治疗视而不见。
对于N=120名参与者(每组60名),我们可以检测到主要和次要影响的中等大小
结果。研究结果将为LW-EDS的新治疗提供数据支持,并提供可靠的理论依据
为患有LW-EDS的儿童和家庭理解病理学的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS B HILDEBRANDT其他文献
THOMAS B HILDEBRANDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS B HILDEBRANDT', 18)}}的其他基金
General Brain Arousal and Risk for Eating Disorder
一般大脑唤醒和饮食失调的风险
- 批准号:
10365378 - 财政年份:2021
- 资助金额:
$ 78.62万 - 项目类别:
General Brain Arousal and Risk for Eating Disorder
一般大脑唤醒和饮食失调的风险
- 批准号:
10656518 - 财政年份:2021
- 资助金额:
$ 78.62万 - 项目类别:
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders
低体重饮食失调青少年的奖励制度和食物避免
- 批准号:
9334942 - 财政年份:2016
- 资助金额:
$ 78.62万 - 项目类别:
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders
低体重饮食失调青少年的奖励系统和食物避免
- 批准号:
10222953 - 财政年份:2016
- 资助金额:
$ 78.62万 - 项目类别:
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Noom Monitor 移动应用程序在暴食者中创新地使用 CBT-GSH
- 批准号:
8521678 - 财政年份:2013
- 资助金额:
$ 78.62万 - 项目类别:
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Noom Monitor 移动应用程序在暴食者中创新地使用 CBT-GSH
- 批准号:
8665495 - 财政年份:2013
- 资助金额:
$ 78.62万 - 项目类别:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
外观和性能增强药物使用的生物行为后果
- 批准号:
7530230 - 财政年份:2008
- 资助金额:
$ 78.62万 - 项目类别:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
外观和性能增强药物使用的生物行为后果
- 批准号:
8269936 - 财政年份:2008
- 资助金额:
$ 78.62万 - 项目类别:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
外观和性能增强药物使用的生物行为后果
- 批准号:
8081856 - 财政年份:2008
- 资助金额:
$ 78.62万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.62万 - 项目类别:
Research Grant














{{item.name}}会员




